Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (964)	7/15/1997 2:06:00 AM
From: JOHN W.	of 6136

I just talked to a friend of mine at AGPH. This H&Q precaution is based on St.Petersburg. This whole thing will eventually turn out to be very positive for AGPH. The AIDS Treatment Data Network and Project Inform will sponsor a meeting on the HIV drug resistance issues this Thursday in N.Y., 7/17/97. Anyone can call to listen to the meeting toll free. Call 1-800-292-9605 for details. I will make a full report on the meeting which will be largely based on St.Petersburg. I bet Amy will be there. When the dust settles, nelf will eventually become widely recognized as the first line PI. Read the results from St. Petersburg for yourself (the entire report) before panic selling tommorrow because of H&Q: healthcg.com Bill, I will respond to your post soon. Dave, note the sponsor for the above site. Regards, John.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next